But, as with any drug, GLP-1s should be used under the close supervision of a health care professional and sourced from state-licensed pharmacies
One in vitro study appears to suggest the half-life of DSIP to be around 15 minutes, while animal studies suggest 4-5 minutes
Moreover, no inactivating mutation of GSTM2 has been found in human or house mouse
Obesity Canada lists three effective interventions for treating obesity: Behavioural (i.e., behavioural therapy, nutrition therapy, physical activity) Pharmacological (i.e., Health Canada-approved prescription medication, including semaglutide) Surgical (i.e., metabolic and bariatric surgery) Canadians expect their group benefits plan to cover obesity treatments Benefits Canadas Healthcare Survey 2025 report found: 65% of plan members agree that weight loss medications are an important obesity treatment
These treatments rely on personalized dosing strategies to ensure the best outcomes for individual patients
Two doses of both Mounjaro and Zepbound are in a shortage, though the FDA reports availability will improve after July